Form 8-K Galera Therapeutics, For: Jun 04

Go back to Form 8-K Galera Therapeutics, For: Jun 04

Galera Therapeutics (GRTX) Eliminates COO Position

June 7, 2024 7:33 AM EDT

On June 4, 2024, Galera Therapeutics (NASDAQ: GRTX) notified Robert A. Beardsley, Ph.D., the Companys Chief Operating Officer, that his position is being eliminated in order to save costs as the Company continues to undertake a comprehensive review of strategic alternatives for both the... More